Ulrike Nitz
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 87
- Cancer Genomics and Diagnostics 22
- Oncology 90
- Cancer Treatment and Pharmacology 42
- HER2/EGFR in Cancer Research 35
- Co-authors
- Nadia Harbeck (87 shared papers)Oleg Gluz (90 shared papers)C Liedtke (14 shared papers)Lajos Pusztai (1 shared paper)Nina Gottschalk (1 shared paper)Ronald Kates (55 shared papers)Matthias Christgen (47 shared papers)Hans Kreipe (42 shared papers)
- Journals
- Journal of Clinical Oncology (40 papers)Cancer Research (23 papers)Annals of Oncology (14 papers)Breast Care (9 papers)European Journal of Cancer (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ulrike Nitz
125 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 1.1k
- Oncology 1.5k
- Radiology, Nuclear Medicine and Imaging 331
- Pathology and Forensic Medicine 258
- Pulmonary and Respiratory Medicine 469
Countries citing papers authored by Ulrike Nitz
This map shows the geographic impact of Ulrike Nitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Nitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Nitz more than expected).
Fields of papers citing papers by Ulrike Nitz
This network shows the impact of papers produced by Ulrike Nitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Nitz. The network helps show where Ulrike Nitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrike Nitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Triple-negative breast cancer—current status and future directions Hit paper breakdown → | 2009 | 513 |
| 2 | 2015 | 269 | |
| 3 | 2010 | 126 | |
| 4 | 1999 | 115 | |
| 5 | 2008 | 84 | |
| 6 | 2011 | 80 | |
| 7 | 2019 | 74 | |
| 8 | 2013 | 72 | |
| 9 | 2011 | 67 | |
| 10 | 2008 | 66 | |
| 11 | 2007 | 57 | |
| 12 | 2010 | 41 | |
| 13 | 2009 | 39 | |
| 14 | 2020 | 35 | |
| 15 | 2013 | 28 | |
| 16 | 2018 | 27 | |
| 17 | 2017 | 25 | |
| 18 | 2007 | 25 | |
| 19 | 2017 | 24 | |
| 20 | 2022 | 23 |
About Ulrike Nitz
Ulrike Nitz is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 135 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (87 papers), Advanced Breast Cancer Therapies (44 papers), Cancer Treatment and Pharmacology (42 papers), HER2/EGFR in Cancer Research (35 papers), Cancer Genomics and Diagnostics (22 papers), Breast Lesions and Carcinomas (11 papers), Erythropoietin and Anemia Treatment (8 papers) and BRCA gene mutations in cancer (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.5k citations), Radiology, Nuclear Medicine and Imaging (331 citations), Pathology and Forensic Medicine (258 citations) and Pulmonary and Respiratory Medicine (469 citations). Ulrike Nitz has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Nadia Harbeck, Oleg Gluz, C Liedtke, Lajos Pusztai, Nina Gottschalk, Ronald Kates, Matthias Christgen, Hans Kreipe, Christoph Thomssen and Christian Jackisch. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Care and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.